![William Chou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
William Chou
Chief Executive Officer at
PASSAGE BIO, INC.
Net worth: 31 837 $ as of 2026-06-29
Profile
Dr. William Chou is a President, Chief Executive Officer & Director at Passage Bio, Inc. He is on the Board of Directors at Passage Bio, Inc. Dr. Chou was previously employed as a Chief Executive Officer by Aruvant Sciences, Inc. and a Vice President by Novartis Pharma AG.
He received his undergraduate degree from Princeton University, an MBA from Yale School of Management and a doctorate degree from the University of Pittsburgh School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-15 | 6,524 ( 0.2% ) | 31 837 $ | 2026-06-29 |
William Chou active positions
| Companies | Position | Start |
|---|---|---|
| PASSAGE BIO, INC. | Chief Executive Officer | 2022-10-09 |
Former positions of William Chou
| Companies | Position | End |
|---|---|---|
Aruvant Sciences, Inc.
 Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning | Chief Executive Officer | 2022-09-30 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | 2019-09-30 |
Training of William Chou
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Yale School of Management
 Yale School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Passage Bio, Inc.
 Passage Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of monogenic central nervous system disorders | Health Technology |
Aruvant Sciences, Inc.
Aruvant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapies for hematological diseases utilizing reduced-intensity conditioning | Health Technology |
- Stock Market
- Insiders
- William Chou
Choose MarketScreener 
